Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features

Abbo, 2005, Multidrug-resistant Acinetobacter baumannii, Emerg. Infect. Dis., 11, 22, 10.3201/eid1101.040001

Balachandran, 2015, Antimicrobial and cytotoxic properties of Streptomyces sp. (ERINLG-51) isolated from Southern Western Ghats, South Indian J. Biol. Sci., 1, 7, 10.22205/sijbs/2015/v1/i1/100436

Basri, 2015, Burden of bacterial meningitis: a retrospective review on laboratory parameters and factors associated with death in meningitis, Kelantan Malaysia, Nagoya J. Med. Sci., 77, 59

Beggs, 2006, Acinetobacter spp. and the clinical environment, Indoor Built Environ., 15, 19, 10.1177/1420326X06062501

Bergogne-Berezin, 1996, Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features, Clin. Microbiol. Rev., 9, 148, 10.1128/CMR.9.2.148

Bonomo, 2006, Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa, Clin. Infect. Dis., 43, S49, 10.1086/504477

Brisou, 1957, Classification of Pseudomonadaceae, Ann. Inst. Pasteur., 93, 397

Brisou, 1954, Studies on bacterial taxonomy. X. The revision of species under Acromobacter group, Ann. Inst. Pasteur., 86, 722

Cisneros, 2002, Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment, Clin. Microbiol. Infect., 8, 687, 10.1046/j.1469-0691.2002.00487.x

Dijkshoorn, 2008, The diversity of the genus Acinetobacter

Dinc, 2015, Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii, N. Microbiol., 38, 67

Doi, 2007, 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides, Clin. Infect. Dis., 45, 88, 10.1086/518605

Doughari, 2011, The ecology, biology and pathogenesis of Acinetobacter spp.: an overview, Microbes Environ., 26, 101, 10.1264/jsme2.ME10179

Ebringer, 2015, An ante-mortem test for bovine spongiform encephalopathy involving “myelin-acinetobacter-neurofilaments” (MAN) tested in 12 strains of Acinetobacter bacteria, 67

Eliopoulos, 2008, Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options, Clin. Infect. Dis., 46, 1254, 10.1086/529198

Erridge, 2007, Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling, J. Med. Microbiol., 56, 165, 10.1099/jmm.0.46823-0

Falagas, 2015, Tetracyclines for multidrug-resistant Acinetobacter baumannii infections, Int. J. Antimicrob. Agents, 10.1016/j.ijantimicag.2014.12.031

Fournier, 2006, The epidemiology and control of Acinetobacter baumannii in health care facilities, Clin. Infect. Dis., 42, 692, 10.1086/500202

Gallagher, 2015, Resources for genetic and genomic analysis of emerging pathogen Acinetobacter baumannii, J. Bacteriol., 10.1128/JB.00131-15

Garnacho-Montero, 2015, Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia, Expert Rev. Anti Infect. Ther., 1

Gerner-Smidt, 1987, The epidemiology of Acinetobacter calcoaceticus: biotype and resistance-pattern of 328 strains consecutively isolated from clinical specimens, Acta Pathol. Microbiol. Scand. Ser. B, 95, 5

Gheorghe, 2015, Snapshot on carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii in Bucharest hospitals reveals unusual clones and novel genetic surroundings for blaOXA-23, J. Antimicrob. Chemother., 70, 1016, 10.1093/jac/dku527

Guide, A.A., 2010. Guide to the Elimination of multidrug-resistant Acinetobacter baumannii transmission in healthcare settings. 36th Annual APIC Educational Conference and International Meeting Proceedings, Fort Lauderdale, FL. 2009 Jun 10.

Houang, 2001, Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong, J. Clin. Microbiol., 39, 228, 10.1128/JCM.39.1.228-234.2001

Islahi, 2015, Incidence and risk factors associated with Acinetobacter species infection in hospitalised patients in a tertiary care hospital in North-India, J. Commun. Dis., 46, 10

Jain, 2004, Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians, Ann. Pharmacother., 38, 1449, 10.1345/aph.1D592

Jung, 2015, Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives, Appl. Microbiol. Biotechnol., 99, 2533, 10.1007/s00253-015-6439-y

Juni, 1969, Transformation of Acinetobacter calcoaceticus (Bacterium anitratum), J. Bacteriol., 98, 281, 10.1128/JB.98.1.281-288.1969

Kamolvit, 2015, Molecular epidemiology and mechanisms of carbapenem resistance of Acinetobacter spp. in Asia and Oceania, Microb. Drug Resist., 21, 424, 10.1089/mdr.2014.0234

Kanafani, A.Z., Kanj, S.S., 2014. Ministry of Health, Kingdome of Saudi Arabia. <http://www.uptodate.com/contents/acinetobacter-infection-treatment-and-prevention>.

Karageorgopoulos, 2008, Current control and treatment of multidrug-resistant Acinetobacter baumannii infections, Lancet Infect. Dis., 8, 751, 10.1016/S1473-3099(08)70279-2

Kurcik-Trajkovska, 2009, Acinetobacter spp. – a serious enemy threatening hospitals worldwide, Maced. J. Med. Sci., 2, 157, 10.3889/MJMS.1857-5773.2009.0043

Lambert, 1993, Characterization of Acinetobacter haemolyticus aac (6′)-Ig gene encoding an aminoglycoside 6′-N-acetyltransferase which modifies amikacin, Antimicrob. Agents Chemother., 37, 2093, 10.1128/AAC.37.10.2093

Lee, 2011, Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens, Yonsei Med. J., 52, 879, 10.3349/ymj.2011.52.6.879

Luna, 2007, Nosocomial acinetobacter pneumonia, Respirology, 12, 787, 10.1111/j.1440-1843.2007.01147.x

Manchanda, 2010, Multidrug resistant acinetobacter, J. Global Infect. Dis., 2, 291, 10.4103/0974-777X.68538

Mugnier, 2008, Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates, Clin. Microbiol. Infect., 14, 879, 10.1111/j.1469-0691.2008.02056.x

Mugnier, 2009, Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain, J. Antimicrob. Chemother., 63, 1071, 10.1093/jac/dkp052

Munoz-Price, 2008, Acinetobacter infection, N. Engl. J. Med., 358, 1271, 10.1056/NEJMra070741

Nowak, 2015, Prevalence of eight RND-efflux pump genes in epidemiologically characterised Acinetobacter baumannii of worldwide origin, J. Med. Microbiol., 000069

Peleg, 2008, Acinetobacter baumannii: emergence of a successful pathogen, Clin. Microbiol. Rev., 21, 538, 10.1128/CMR.00058-07

Perez, 2007, Global challenge of multidrug-resistant Acinetobacter baumannii, Antimicrob. Agents Chemother., 51, 3471, 10.1128/AAC.01464-06

Pogue, 2015, Polymyxin-resistant Acinetobacter baumannii: urgent action needed, Clin. Infect. Dis., 60, 1304

Potron, 2015, Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology, Int. J. Antimicrob. Agents, 45, 568, 10.1016/j.ijantimicag.2015.03.001

Saeed, 2010, Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia, Saudi Med. J., 31, 1341

Seifert, 1997, Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods, J. Clin. Microbiol., 35, 2819, 10.1128/JCM.35.11.2819-2825.1997

Sherertz, 1985, An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients’ mattresses, J. Infect. Dis., 151, 252, 10.1093/infdis/151.2.252

Smith, 2007, New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis, Genes Dev., 21, 601, 10.1101/gad.1510307

Tomaras, A.P., Dorsey, C.W., Mcqueary, C., Actis, L.A., 2008. Molecular basis of Acinetobacter virulence and pathogenicity. In: Acinetobacter Molecular Microbiology.

Towner, 2006, The genus Acinetobacter, 746

Towner, 2015, Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care

Urban, 2003, Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii, Clin. Infect. Dis., 36, 1268, 10.1086/374847

Utnes, 2015, Growth phase-specific evolutionary benefits of natural transformation in Acinetobacter baylyi, ISME J., 10.1038/ismej.2015.35

Vashist, 2011, Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii, Indian J. Med. Res., 133, 332

Villegas, 2003, Acinetobacter outbreaks, 1977–2000, Infect. Control, 24, 284

Vourli, 2015, Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients, Int. J. Antimicrob. Agents, 10.1016/j.ijantimicag.2015.02.005

Weernink, 1995, Pillows, an unexpected source of Acinetobacter, J. Hosp. Infect., 29, 189, 10.1016/0195-6701(95)90328-3

Whitman, 2008, Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker, Clin. Infect. Dis., 47, 439, 10.1086/589247

Yadav, 2015, Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii, Antimicrob. Agents Chemother., 59, 2286, 10.1128/AAC.04379-14

Yang, 2015, Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Acinetobacter baumannii in China, J. Chemother.

Zowawi, 2015, Molecular epidemiology of carbapenem resistant Acinetobacter baumannii in the Gulf Cooperation Council States. Dominance of OXA-23-type producers, J. Clin. Microbiol., 10.1128/JCM.02784-14